Product Images Fentanyl Citrate

This text provides instructions for titrating the dosage of oral transmucosal fentanyl citrate for the treatment of breakthrough pain. The initial dose should be 200 mcg and no more than 6 units should be dispensed. The patient should consume one unit over 15 minutes and wait for 15 more minutes. If needed, only one additional unit may be consumed over 16 minutes. It is advised not to take more than 2 units per breakthrough pain episode and wait for at least 4 hours before treating another episode of breakthrough pain with oral transmucosal fentanyl citrate. The available dosage strengths include 200, 400, 600, 800, 1200, and 1600 mcg.*

Mallinckrodt manufactured NDC 0406-9202-30, which is a prescription drug containing Fentanyl Citrate. This medicine is only intended for patients who are already taking opioids such as fentanyl or morphine. It is available in 30 units and is considered habit-forming. It is essential to keep this medication out of children's reach as it could be harmful or fatal if unintentionally ingested. To avoid any complications, pharmacists are required to dispense the medicine with a medication guide that contains significant warnings and directions.*

Mallinckrodt is a prescription-only drug indicated for patients already taking narcotics like fentanyl or morphine. It comes in an oral transmucosal form containing Fentanyl Citrate and is equivalent to 400 MC. The drug may be habit-forming and should be dispensed with a Medication Guide. It is essential to keep it out of reach of children as accidental ingestion could be harmful or fatal. It is necessary to read the enclosed medication guide for vital warnings and directions.*

This is a medication called Mallinckrodt, which contains oral Transmucosal Fentanyl Citrate. It is only recommended for patients who are already taking opioids such as fentanyl or morphine. The medication is habit-forming and may be harmful or fatal if accidentally ingested by a child. It is important to read the enclosed medication guide for important warnings and directions before use.*

This is a medication description for Mallinckrodt's oral transmucosal fentanyl citrate. It is intended only for patients already taking opioids such as fentanyl or morphine. Each package contains 30 units with an NDC code of 0406-9208-30. One unit is equivalent to 800 MCQ fentanyl base, and it may be habit-forming. The pharmacist should dispense the product with the medication guide, and users should keep it out of reach of children, as it can be fatal if ingested accidentally. The enclosed medication guide contains important warnings and directions for safe use.*

Mallinckrodt's Oral Transmucosal Fentanyl Citrate is a prescription medication and only for patients already taking opioids. It is administered with a unit of 30 and contains 1200 MCQ fentanyl base, which may be habit-forming. The pharmacist is advised to dispense the medicine along with a medication guide. There is a warning to keep this medicine out of the reach of children as accidental ingestion could be harmful or fatal. The enclosed oral transmucosal fentanyl citrate medication guide contains crucial warnings and instructions that must be read.*

The text describes a medication called Mallinckrodt, which has an NDC number 0406-9216-30 and contains 30 units. It is only recommended for patients who are already taking opioids like fentanyl or morphine. The medication is in the form of Oral Transmucosal C Fentanyl Citrate and is only available with a prescription. The medication is equivalent to 1600 MC of fentanyl base and has warnings that it may be habit-forming. The pharmacist is advised to dispense the medication with a medication guide. The medication should be kept out of the reach of children, as accidental ingestion can be harmful or fatal. The enclosed oral transmucosal fentanyl citrate Medication Guide should be read for important warnings and directions.*

The text provides a summary of pain relief scores for people who received transmucosal fentanyl citrate compared to those who received a placebo. The scores were measured at different intervals, starting from the administration of the drug and measured up to at least 60 minutes. The statistical significance of the difference in scores was high (p-values <0.0001). The text does not provide information on the size of the sample or the conditions for the study.*